Meta-analyses confirm significantly elevated serum IL-6 levels in asthma patients, correlating with disease severity, exacerbation frequency, and impaired lung function [38], while IL6R inhibition also demonstrates therapeutic benefits in T2DM patients [39]. Here, IL6R is linked to asthma.